FindTrial
Sign In

Patient Experiences Following Urinary Diversion as Part of Surgery for Advanced and Recurrent Rectal Cancer

Surgical and patient-entered experiences following urinary reconstruction after pelvic exenteration for locally advanced and recurrent rectal cancer - PelvEx 3

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039441
Enrollment
1200
Registered
2022-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C20- Malignant neoplasm of rectum

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Histologically proven advanced rectal cancer -Must have urinary diversion / reconstruction -Able and willing to give written informed consent -Able to assess email/internet

Exclusion criteria

Exclusion criteria: -Strong evidence of metastatic or peritoneal disease -Palliative exenteration -Colonic obstruction -Pelvic exenteration for non-rectal neoplasm -Inability to answer online questionnaires

Design outcomes

Primary

MeasureTime frame
To determine the 30-day complication rate of urinary diversion/reconstruction following pelvic exenteration -To assess the impact of urinary diversion/reconstruction subtypes on quality of life at: Day-30,Month 3, Month 6 ,year 1 Timepoint: 12 months—

Secondary

MeasureTime frame
-To assess the short/medium-term complications associated with the subtypes of urinary diversion/reconstruction at 6-months and 1- -To assess the rate of intervention to modify or intervene due to urinary diversion/reconstruction complicationsTimepoint: 12 month—

Countries

India, Ireland

Contacts

Public ContactAvanish Saklani

Tata Memorial Centre

asaklani@hotmail.com7400319886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026